Durvalumab (Genetical Recombination) (500Mg 10Ml/V...

FREE TRIAL

Get Access to 1 Million Global Tenders

You are Successfully Registered to zimbabwetenders!!

Email Id is already exist !!

Something went wrong !!

Publish Tenders

Click here to publish tender and gain more visibility worldwide.

Subscription Plans

Click here to upgrade to a Premium Plan.

100% Secure Payments

Tender Details

Download Tender Documents

Country: Japan
Summary: Durvalumab (Genetical Recombination) (500Mg 10Ml/Vial) 90 Vials
JPT Ref No: 105259647
Deadline: 25 Sep 2024
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.:
Purchaser's Detail :

Purchaser : NATIONAL UNIVERSITY CORPORATION
Tobioka Naoki, Medicine Section, Financial Division, Hokkaido University Hospital, Kita 14 Nishi 5 Kita-Ku Sapporo-Shi 060-8648 Japan, Tel 011-706-7405

Description :
Durvalumab (Genetical Recombination) (500mg 10ml/vial) 90 vials
Documents :

Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Tender Category

Construction and Real Estate

Energy and Related Services

IT & Softwares

All Categories

Create New Account

JapanTenders Features

Fresh and verified Tenders from Japan. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

1,000+ Tenders
Verified Tenders Only
Accurate Tender Information
New Tenders Every Day
Consultants for RFI/RFP/RFQ

Search, sort, and filter Tenders
Customer Support
Publish your Tenders
Consulting Services
Export data to Excel or CRM

Get Daily Tender Alerts

Durvalumab (Genetical Recombination) (500Mg 10Ml/Vial) 90 Vials